Skip to main content

Table 2 Univariate analysis of predictors for all-cause mortality

From: Prognostic value of the modified model for end-stage liver disease (MELD) score including albumin in acute heart failure

  HR (95% CI) P value
Age (per year increase) 1.00 (1.00, 1.01) 0.016
Male 0.55 (0.41, 0.73)  < 0.001
Diabetes 1.01 (0.74, 1.39) 0.936
Hypertension 0.87 (0.66, 1.15) 0.327
Ischemic heart failure 1.12 (0.82, 1.54) 0.483
NYHA   
II 1.00  
III 1.63 (1.05, 2.54) 0.031
IV 2.01 (1.25, 3.21) 0.004
Heart rate (per beats/min increase) 1.00 (0.99, 1.00) 0.521
Systolic blood pressure (per mmHg increase) 0.99 (0.99, 1.00) 0.023
Diastolic blood pressure (per mmHg increase) 0.98 (0.97, 0.99) 0.001
Potassium (per mmol/L increase) 1.08 (0.81, 1.42) 0.612
Uric acid (per mg/dL increase) 1.05 (0.99, 1.10) 0.057
ALT (per U/L increase) 1.00 (1.00, 1.00) 0.598
AST (per U/L increase) 1.00 (1.00, 1.00) 0.659
proBNP (per ng/L increase) 1.00 (1.00, 1.00)  < 0.001
CRP (per mg/L increase) 1.01 (0.99, 1.03) 0.082
Anemia 1.22 (0.82, 1.80) 0.325
LVEF (per 1 unit increase) 0.98 (0.97, 0.99) 0.001
Pulmonary hypertension 1.69 (1.26, 2.28) 0.001
Tricuspid regurgitation   
No 1.00  
Mild 0.96 (0.54, 1.71) 0.890
Moderate 1.16 (0.65, 2.09) 0.619
Severe 1.74 (0.96, 3.14) 0.068
RVDd (per mm increase) 1.02 (1.00, 1.04) 0.056
Body mass index (per kg/M2 increase) 0.98 (0.95, 1.00) 0.082
Antisterone 1.13 (0.70, 1.81) 0.622
ACEI/ARB 0.94 (0.67, 1.31) 0.699
Beta-blocker 0.79 (0.57, 1.10) 0.163
Aspirin 1.08 (0.82, 1.44) 0.583
  1. NYHA New York Heart Association functional class, ALT alanine aminotransferase, AST aspartate aminotransaminase, LVEF left ventricular ejection fraction, ACEI angiotensin converting enzyme inhibitors, ARB angiotensin receptor blocker